Finasteride

Finasteride contains the active ingredient finasteride, a selective 5-alpha-reductase inhibitor. This enzyme converts testosterone into dihydrotestosterone (DHT), an androgen involved in male pattern baldness and benign prostate enlargement.

Finasteride contains the active ingredient finasteride, a selective 5-alpha-reductase inhibitor. This enzyme converts testosterone into dihydrotestosterone (DHT), an androgen involved in male pattern baldness and benign prostate enlargement.

Male pattern baldness is a progressive condition. In genetically susceptible follicles, DHT shortens the growth phase and makes each new hair shaft finer. Over time, follicles can become too small to produce visible terminal hairs.

Finasteride reduces the conversion of testosterone to DHT. Lower DHT exposure can protect vulnerable follicles from further miniaturisation. It does not create new follicles, so its strongest role is usually preserving hair that is still present.

The FDA-approved prescribing information describes finasteride as a treatment for male pattern hair loss in men, with benefit assessed through changes in hair count and appearance over sustained treatment. ^[1]

• Take the prescribed dose of Finasteride orally as a pill once daily.
• Take it with or without food, at a time of day that suits your routine.
• Swallow the pill whole with water.
• Continue treatment for the duration stated by your prescriber; ongoing use is needed to maintain the effect.
• The exact dose in mg is stated on the prescription or pack. If a dose is missed, take the next scheduled dose at the usual time and do not take a double dose.

Finasteride acts beneath the scalp rather than directly on the hair shaft. Its effect comes from reducing DHT in the blood and scalp tissues. That gives affected follicles a chance to remain in their active growth cycle for longer.

Finasteride reduces the conversion of testosterone to DHT. Lower DHT exposure can protect vulnerable follicles from further miniaturisation.

It is used when thinning at the crown or recession at the hairline is driven by sensitivity to dihydrotestosterone, or DHT.

The medicine is generally intended for adult men with male pattern baldness.

Finasteride can also be used for benign prostate enlargement, a non-cancerous increase in prostate size that may contribute to weak urine flow, hesitancy, or frequent urination.

Finasteride and minoxidil address male pattern hair loss through different pathways. Finasteride reduces DHT formation. Minoxidil works locally at the scalp and appears to extend the hair-growth phase through effects on follicle signalling and blood flow.

Finasteride is often favoured when the goal is to address the hormonal mechanism of male pattern baldness. Topical minoxidil may suit someone who cannot use a DHT-lowering medicine or prefers a scalp-based approach. Oral minoxidil needs medical oversight because it has cardiovascular effects that topical treatment does not share.

Combination treatment is sometimes used under prescriber guidance, since the two approaches are mechanistically different. More treatment is not automatically better for every person, and side-effect burden still matters.

Several avoidable mistakes can make Finasteride seem less useful than it is:

• Expecting visible regrowth within a few weeks.
• Taking tablets irregularly, then judging the treatment after short bursts of use.
• Assuming increased shedding always means permanent worsening rather than a temporary hair-cycle change.
• Comparing daily mirror images instead of consistent photographs taken months apart.
• Ignoring a sudden change in hair-loss pattern that may have a non-hormonal cause.
• Continuing treatment despite new sexual or mood symptoms without discussing them with the prescriber.

One tablet is easy to overlook. Linking it to an established routine, such as brushing teeth, helps maintain consistency.

In clinical practice, prescribers usually set expectations around maintenance rather than dramatic regrowth. A man with early thinning and active follicles often has more to preserve than someone with long-standing smooth bald areas.

Doctors also look for the pattern of hair loss. A widening crown and gradual temple recession fit androgenetic alopecia more closely than sudden shedding after fever, a sharply defined bald patch, or an itchy inflamed scalp. Those patterns may need a different assessment.

A practical benchmark is to compare similar photographs taken under the same lighting every few months. Daily mirror checks are misleading because hair length, styling, humidity, and overhead light can make density look different.